908 Devices Inc.
Financials
Valuation Metrics
908 Devices Inc.'s Market Cap is $422M. At end of 2025 it was $190M. Ranked #2723 of 3,116 in US market (top 87%), #1182 of 1,472 on NASDAQ (top 80%), #170 of 203 in Health Care Equipment & Services (top 84%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $422M | US#2,723/3,116 Sec#170/203 |
| Revenue | $61M | US#2,728/3,116 Sec#194/203 |
| Net Income | $-34M | US—/3,116 Sec—/203 |
| Total Assets | $198M | US#2,983/3,116 Sec#185/203 |
| Net Assets | $127M | US#2,765/3,116 Sec#175/203 |
| Employees | 172 | US#2,502/3,116 Sec#173/203 |
| Value | ||
| P/B | 3.33x | US#2,070/3,116 Sec#115/203 |
| P/S | 6.93x | US#2,639/3,116 Sec#176/203 |
| FCF Yield | 0.12% | US#2,251/3,116 Sec#142/203 |
| Profitability | ||
| ROE | -27.20% | US#2,538/3,116 Sec#155/203 |
| ROA | -17.46% | US#2,759/3,116 Sec#169/203 |
| Op. Margin | -46.01% | US#2,650/3,116 Sec#180/203 |
| Revenue Growth | 4.62% | US#1,801/3,116 Sec#136/203 |
| Financial Health | ||
| Debt Ratio | 55.83% | US#639/3,116 Sec#71/203 |
| Total Debt | $4M | US#2,903/3,116 Sec#196/203 |
| FCF | $494000.00 | US#2,275/3,116 Sec#143/203 |
| Cash | $63M | US#2,471/3,116 Sec#154/203 |
| Current Ratio | 2.67x | US#888/3,116 Sec#92/203 |
| Performance | ||
| 1Y Return | 27.82% | US#337/3,116 Sec#37/203 |
| 1M Return | -19.62% | US#882/3,116 Sec#89/203 |
| From 52W High | -23.60% | US#368/3,116 Sec#45/203 |
| 1Y MDD | -37.16% | US#1,772/3,116 Sec#109/203 |
| Trading | ||
| Volume | 404,965 shares | US#2,633/3,116 Sec#182/203 |
| Trading Value | $4M | US#2,828/3,116 Sec#183/203 |
| Per Share | ||
| EPS | $-0.83 | US—/3,116 Sec—/203 |
| BPS | $3.07 | US#2,478/3,116 Sec#163/203 |
Company Info
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.